Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Ischemic Heart Disease

Free Subscription Articles published in Eur Heart J Retrieve available abstracts of 297 articles: HTML format

Single Articles

April 2021
1. CREA F
   Guidelines on myocardial infarction, novel therapeutic targets in post-infarction remodelling, and a debate on the ISCHEMIA trial.
   Eur Heart J. 2021;42:1277-1280.
   PubMed    
   
   
   March 2021
2. FRIGERIO M
   Fausto Rovelli (1918-2021): the father of Italian cardiology, pioneer of early reperfusion therapy for acute myocardial infarction, and unforgettable master for his hospital colleagues.
   Eur Heart J. 2021 Mar 29. pii: 6199127. doi: 10.1093.
   PubMed    
   
   
   
3. FIOLET ATL, Opstal TSJ, Mosterd A, Eikelboom JW, et al
   Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials.
   Eur Heart J. 2021 Mar 26. pii: 6188997. doi: 10.1093.
   PubMed     Abstract available
   
   
   
4. KWOK CS, Wong CW, Kontopantelis E, Barac A, et al
   Percutaneous coronary intervention in patients with cancer and readmissions within 90 days for acute myocardial infarction and bleeding in the USA.
   Eur Heart J. 2021;42:1019-1034.
   PubMed     Abstract available
   
   
   February 2021
5. CEGLAREK U, Schellong P, Rosolowski M, Scholz M, et al
   The novel cystatin C, lactate, interleukin-6, and N-terminal pro-B-type natriuretic peptide (CLIP)-based mortality risk score in cardiogenic shock after acute myocardial infarction.
   Eur Heart J. 2021 Feb 27. pii: 6153946. doi: 10.1093.
   PubMed     Abstract available
   
   
   
6. REFFO E, Stritoni V, Di Salvo G
   Inflammatory syndrome in children associated with COVID-19 complicated by acute myocardial infarction.
   Eur Heart J. 2021 Feb 20. pii: 6145783. doi: 10.1093.
   PubMed    
   
   
   
7. BOUABDALLAOUI N, Tardif JC
   Initiation of low-dose colchicine early after myocardial infarction.
   Eur Heart J. 2021 Feb 4. pii: 6127594. doi: 10.1093.
   PubMed    
   
   
   
8. HARTIALA JA, Han Y, Jia Q, Hilser JR, et al
   Genome-wide analysis identifies novel susceptibility loci for myocardial infarction.
   Eur Heart J. 2021 Feb 3. pii: 6126843. doi: 10.1093/eurheartj/ehaa1040.
   PubMed     Abstract available
   
   
   
9. BERGONTI M
   Emergency Room visits in the COVID-19 pandemic.
   Eur Heart J. 2021;42:369-370.
   PubMed    
   
   
   January 2021
10. XING Y, Dai N, Li H
    Is abnormal function with troponin T elevation definitely myocardial infarction?
    Eur Heart J. 2021 Jan 30. pii: 6124030. doi: 10.1093.
    PubMed    
    
    
    
11. VRACHATIS DA, Giannopoulos GV, Deftereos SG
    Colchicine administered early in acute myocardial infarction: ready, set ... go?
    Eur Heart J. 2021 Jan 22. pii: 6106966. doi: 10.1093.
    PubMed    
    
    
    
12. 
    Corrigendum to: Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era.
    Eur Heart J. 2021;42:322.
    PubMed    
    
    
    
13. KOLBE M, Lopez-Ayala P, Mueller C
    Women who experience a myocardial infarction at a young age.
    Eur Heart J. 2021 Jan 19. pii: 6104220. doi: 10.1093.
    PubMed    
    
    
    
14. CHATTOPADHYAY S, John J
    Women experiencing myocardial infarction at a young age have worse outcomes compared with men: only for non-cardiovascular deaths and when treated inadequately?
    Eur Heart J. 2021 Jan 17. pii: 6103003. doi: 10.1093.
    PubMed    
    
    
    
15. HOLT A, Blanche P, Zareini B, Rajan D, et al
    Effect of long-term beta-blocker treatment following myocardial infarction among stable, optimally treated patients without heart failure in the reperfusion era: a Danish, nationwide cohort study.
    Eur Heart J. 2021 Jan 11. pii: 6082772. doi: 10.1093/eurheartj/ehaa1058.
    PubMed     Abstract available
    
    
    
16. MONACO C, Cole J
    Does a myocardial infarction boost your (B cell) memory?
    Eur Heart J. 2021 Jan 4. pii: 6061967. doi: 10.1093/eurheartj/ehaa1059.
    PubMed    
    
    
    December 2020
17. SCHUBERT J, Lindahl B, Melhus H, Renlund H, et al
    Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study.
    Eur Heart J. 2020 Dec 24. pii: 6047259. doi: 10.1093/eurheartj/ehaa1011.
    PubMed     Abstract available
    
    
    
18. FIOLET ATL, Nidorf SM, Cornel JH
    Colchicine for secondary prevention in coronary disease.
    Eur Heart J. 2020 Dec 21. pii: 6042608. doi: 10.1093.
    PubMed    
    
    
    
19. KYAW T, Loveland P, Kanellakis P, Cao A, et al
    Alarmin-activated B cells accelerate murine atherosclerosis after myocardial infarction via plasma cell-immunoglobulin-dependent mechanisms.
    Eur Heart J. 2020 Dec 18. pii: 6041767. doi: 10.1093.
    PubMed     Abstract available
    
    
    
20. KOTANIDIS CP, Antoniades C
    Selfies in cardiovascular medicine: welcome to a new era of medical diagnostics.
    Eur Heart J. 2020;41:4412-4414.
    PubMed    
    
    
    
21. LI L, Fu W, Gong X, Chen Z, et al
    The role of G protein-coupled receptor kinase 4 in cardiomyocyte injury after myocardial infarction.
    Eur Heart J. 2020 Dec 6. pii: 6024960. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2020
22. ORWAT S, Diller GP
    Congenital heart defects as an intrinsic additional risk factor for the occurrence and outcome of myocardial infarction.
    Eur Heart J. 2020 Nov 22. pii: 5998317. doi: 10.1093.
    PubMed    
    
    
    
23. FEDCHENKO M, Mandalenakis Z, Giang KW, Rosengren A, et al
    Long-term outcomes after myocardial infarction in middle-aged and older patients with congenital heart disease-a nationwide study.
    Eur Heart J. 2020 Nov 21. pii: 5997447. doi: 10.1093.
    PubMed     Abstract available
    
    
    
24. MUNZEL T, Hahad O, Daiber A
    The dark side of nocturnal light pollution. Outdoor light at night increases risk of coronary heart disease.
    Eur Heart J. 2020 Nov 21. pii: 5998262. doi: 10.1093.
    PubMed    
    
    
    
25. BOHM M, Mahfoud F
    J-curve revisited.
    Eur Heart J. 2020;41:4283.
    PubMed    
    
    
    
26. LIEW CH, McEvoy JW
    The diastolic blood pressure J-curve remains an observational research phenomenon that has not yet been proven as causal and should not be used to make invasive treatment decisions.
    Eur Heart J. 2020;41:4284-4285.
    PubMed    
    
    
    
27. SUN S, Cao W, Ge Y, Ran J, et al
    Outdoor light at night and risk of coronary heart disease among older adults: a prospective cohort study.
    Eur Heart J. 2020 Nov 17. pii: 5986682. doi: 10.1093.
    PubMed     Abstract available
    
    
    
28. NEUVILLERS L, Veugeois A, Didier J, Paul JF, et al
    Myocardial infarction with non-obstructive coronary artery revealing a heart tumour.
    Eur Heart J. 2020 Nov 13. pii: 5981589. doi: 10.1093.
    PubMed    
    
    
    
29. NICHOLLS M
    Australia and colchicine for coronary heart disease.
    Eur Heart J. 2020 Nov 10. pii: 5961660. doi: 10.1093.
    PubMed    
    
    
    
30. LUSCHER TF
    The sooner, the better: anti-inflammation in acute myocardial infarction.
    Eur Heart J. 2020;41:4100-4102.
    PubMed    
    
    
    
31. VRACHATIS DA, Deftereos S, Stefanini GG
    STEMI in COVID-19 patients: thrombolysis-first approach could yield more risk than benefit.
    Eur Heart J. 2020;41:4141-4142.
    PubMed    
    
    
    
32. ZHANG L, Fan Y, Lu Z
    Compromised STEMI reperfusion strategy in the era of COVID-19 pandemic: pros and cons.
    Eur Heart J. 2020;41:4143.
    PubMed    
    
    
    
33. CANNON CP
    Chronic kidney disease: a high-risk group that deserves intensive lipid lowering.
    Eur Heart J. 2020;41:4124-4126.
    PubMed    
    
    
    
34. MELE M, Casavecchia G, Ieva R, Brunetti ND, et al
    Diagnosis of acute myocardial infarction in the time of the COVID-19 pandemic.
    Eur Heart J. 2020 Nov 4. pii: 5956256. doi: 10.1093.
    PubMed    
    
    
    October 2020
35. LANDMESSER U, Luscher TF
    Advancing RNA-targeted therapy for personalised prevention of coronary disease: focus on ANGPLT3.
    Eur Heart J. 2020;41:3946-3948.
    PubMed    
    
    
    
36. TOKGOZOGLU L, Catapano AL
    Can EPA evaporate plaques?
    Eur Heart J. 2020;41:3933-3935.
    PubMed    
    
    
    
37. BALLANTYNE CM, Virani SS
    Real-world data, theoretical application of guidelines, cost, and access: how do we optimize non-statin therapy for LDL-C/non-HDL-C/ApoB?
    Eur Heart J. 2020;41:3910-3912.
    PubMed    
    
    
    
38. CHANDRASEKAR B, Alanbaei M
    Intracoronary imaging identifies plaque rupture underlying left main thrombosis in acute myocardial infarction without angiographically evident atherosclerosis.
    Eur Heart J. 2020 Oct 14. pii: 5922862. doi: 10.1093.
    PubMed    
    
    
    
39. BONNET M, Champagnac A, Lantelme P, Harbaoui B, et al
    Endomyocardial biopsy findings in Kawasaki-like disease associated with SARS-CoV-2.
    Eur Heart J. 2020;41:3863-3864.
    PubMed    
    
    
    
40. TWEET MS
    Sex differences among young individuals with myocardial infarction.
    Eur Heart J. 2020 Oct 13. pii: 5921646. doi: 10.1093.
    PubMed    
    
    
    
41. DEFILIPPIS EM, Collins BL, Singh A, Biery DW, et al
    Women who experience a myocardial infarction at a young age have worse outcomes compared with men: the Mass General Brigham YOUNG-MI registry.
    Eur Heart J. 2020 Oct 13. pii: 5921645. doi: 10.1093.
    PubMed     Abstract available
    
    
    
42. LIUZZO G, Patrono C
    Low-dose colchicine: a new tool in the treatment of chronic coronary disease? Comment on the low-dose colchicine (LoDoCo)2 trial.
    Eur Heart J. 2020 Oct 7. pii: 5918829. doi: 10.1093.
    PubMed    
    
    
    
43. BOLLI R
    Cell therapy for acute myocardial infarction: Requiescat in Pace.
    Eur Heart J. 2020;41:3711-3714.
    PubMed    
    
    
    
44. LANSKY A, Grubman D, Scheller B
    Paclitaxel-coated balloons: a safe alternative to drug-eluting stents for coronary in-stent restenosis.
    Eur Heart J. 2020;41:3729-3731.
    PubMed    
    
    
    
45. STOREY RF
    The long journey of individualizing antiplatelet therapy after acute coronary syndromes.
    Eur Heart J. 2020;41:3546-3548.
    PubMed    
    
    
    
46. LIUZZO G, Pedicino D, Vinci R, Crea F, et al
    CD8 lymphocytes and plaque erosion: a new piece in the jigsaw.
    Eur Heart J. 2020;41:3561-3563.
    PubMed    
    
    
    September 2020
47. DORING Y, Noels H, van der Vorst E, Weber C, et al
    Seeing is repairing: how imaging-based timely interference with CXCR4 could improve repair after myocardial infarction.
    Eur Heart J. 2020 Sep 11. pii: 5904399. doi: 10.1093.
    PubMed    
    
    
    
48. HESS A, Derlin T, Koenig T, Diekmann J, et al
    Molecular imaging-guided repair after acute myocardial infarction by targeting the chemokine receptor CXCR4.
    Eur Heart J. 2020 Sep 9. pii: 5903166. doi: 10.1093.
    PubMed     Abstract available
    
    
    
49. PARODI G, Sanna GD, Saba PS
    Understanding the complex interplay between coronary artery disease and Takotsubo syndrome: not all swans are white.
    Eur Heart J. 2020;41:3268-3270.
    PubMed    
    
    
    
50. SANZ-RUIZ R, Fernandez-Aviles F
    Cardiovascular regenerative and reparative medicine: is myocardial infarction the model?
    Eur Heart J. 2020 Sep 3. pii: 5900893. doi: 10.1093.
    PubMed    
    
    
    
51. LIBERALE L, Gorog DA
    Low-grade endotoxaemia and platelets: a deadly aggregation.
    Eur Heart J. 2020;41:3166-3168.
    PubMed    
    
    
    
52. SCHUPKE S, Kastrati A
    Mechanistic insights into the superior clinical efficacy of prasugrel over ticagrelor.
    Eur Heart J. 2020;41:3153-3155.
    PubMed    
    
    
    August 2020
53. MATHUR A, Fernandez-Aviles F, Bartunek J, Belmans A, et al
    The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: the BAMI trial.
    Eur Heart J. 2020 Aug 30. pii: 5898841. doi: 10.1093.
    PubMed     Abstract available
    
    
    
54. BOUABDALLAOUI N, Tardif JC, Waters DD, Pinto FJ, et al
    Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT).
    Eur Heart J. 2020 Aug 29. pii: 5898840. doi: 10.1093.
    PubMed     Abstract available
    
    
    
55. KHAN S
    Mast cell tryptase level should be checked in all patients with suspected Kounis syndrome.
    Eur Heart J. 2020;41:3018.
    PubMed    
    
    
    
56. CHATTERJEE NA, Tikkanen JT, Albert CM
    The electrocardiogram and sudden death: capturing electrical physiology and arrhythmic substrate.
    Eur Heart J. 2020;41:2911-2912.
    PubMed    
    
    
    
57. ASATRYAN B, Roten L, Reichlin T
    Identifying coronary artery disease patients at risk for sudden and/or arrhythmic death: remaining limitations of the electrocardiogram.
    Eur Heart J. 2020;41:2911-2912.
    PubMed    
    
    
    July 2020
58. HARARI R, Bangalore S
    Beta-blockers after acute myocardial infarction: an old drug in urgent need of new evidence!
    Eur Heart J. 2020 Jul 30. pii: 5879119. doi: 10.1093.
    PubMed    
    
    
    
59. GILMANOV D, Greco C, Cafaro A, Zaccaria S, et al
    Two coronary artery aneurysms complicated by acute myocardial infarction and treated with open chest surgery.
    Eur Heart J. 2020 Jul 29. pii: 5877568. doi: 10.1093.
    PubMed    
    
    
    
60. WEINGARTNER O, Patel SB, Lutjohann D
    It's time to personalize and optimize lipid-lowering therapy.
    Eur Heart J. 2020;41:2629-2631.
    PubMed    
    
    
    
61. HOWARD JP, Arnold AD, Ahmad Y
    Bias, heterogeneity, and uncertainty in meta-analysis.
    Eur Heart J. 2020;41:2712.
    PubMed    
    
    
    
62. LI Y, Yan L, Shui S, Han X, et al
    Choriocarcinoma metastasis in the left atrium.
    Eur Heart J. 2020;41:2628.
    PubMed    
    
    
    
63. TAN HL, van Dongen LH, Zimmerman DS
    Sudden cardiac death in young patients with diabetes: a call to study additional causes beyond ischaemic heart disease.
    Eur Heart J. 2020;41:2707-2709.
    PubMed    
    
    
    
64. TU S, Westra J, Adjedj J, Wijns W, et al
    Physiological assessment of non-culprit stenoses during acute coronary syndromes.
    Eur Heart J. 2020;41:2598.
    PubMed    
    
    
    
65. BUENO H, Rossello X, Bardaji A
    Has the Fourth Universal Definition of Myocardial Infarction led to better diagnosis and risk stratification?
    Eur Heart J. 2020 Jul 10. pii: 5869541. doi: 10.1093.
    PubMed    
    
    
    
66. WACKER J, Malaspinas I, Aggoun Y, Bordessoule A, et al
    Coronary artery dilatation in a child with hyperinflammatory syndrome with SARS-CoV-2-positive serology.
    Eur Heart J. 2020;41:3103.
    PubMed    
    
    
    June 2020
67. JAYARAJ R, Kumaraswamy C, Shaw P
    Clinical and conceptual approaches to interpreting the findings of systematic review and meta-analysis of mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease.
    Eur Heart J. 2020 Jun 26. pii: 5863013. doi: 10.1093.
    PubMed    
    
    
    
68. STIEKEMA LCA, Hovingh GK, Stroes ESG
    The therapeutic age paradox coming to an end.
    Eur Heart J. 2020;41:2259-2261.
    PubMed    
    
    
    
69. KIM J, Kang D, Park H, Kang M, et al
    Long-term beta-blocker therapy and clinical outcomes after acute myocardial infarction in patients without heart failure: nationwide cohort study.
    Eur Heart J. 2020 Jun 15. pii: 5857797. doi: 10.1093.
    PubMed     Abstract available
    
    
    
70. PAVASINI R, D'Ascenzo F, Campo G
    Moving forward from statistical to clinical considerations regarding complete revascularization.
    Eur Heart J. 2020;41:2225.
    PubMed    
    
    
    
71. JOBS A, Schwarzer G, Thiele H
    Conclusions of complete revascularization meta-analysis are challenged by state-of-the-art methods.
    Eur Heart J. 2020;41:2223-2224.
    PubMed    
    
    
    
72. THYGESEN K, Jaffe AS
    Our nearly complete diagnostic trip of thousands of steps begets a new trip therapeutically.
    Eur Heart J. 2020;41:2217-2219.
    PubMed    
    
    
    
73. KONDAPALLI L, Moslehi J, Bonaca MP
    Inflammation begets inflammation: cancer and acute MI.
    Eur Heart J. 2020;41:2194-2196.
    PubMed    
    
    
    
74. DUSI V, De Ferrari GM, Schwartz PJ
    There are 100 ways by which the sympathetic nervous system can trigger life-threatening arrhythmias.
    Eur Heart J. 2020;41:2180-2182.
    PubMed    
    
    
    
75. HUNG J, Roos A, Kadesjo E, McAllister DA, et al
    Performance of the GRACE 2.0 score in patients with type 1 and type 2 myocardial infarction.
    Eur Heart J. 2020 Jun 9. pii: 5855217. doi: 10.1093.
    PubMed     Abstract available
    
    
    
76. ASHRAF S, Ilyas S, Alraies MC
    Acute coronary syndrome in the time of the COVID-19 pandemic.
    Eur Heart J. 2020;41:2089-2091.
    PubMed    
    
    
    
77. VALENTE S, Anselmi F, Cameli M
    Acute coronary syndromes during COVID-19.
    Eur Heart J. 2020;41:2047-2049.
    PubMed    
    
    
    
78. DOMINGUEZ-ERQUICIA P, Dobarro D, Raposeiras-Roubin S, Bastos-Fernandez G, et al
    Multivessel coronary thrombosis in a patient with COVID-19 pneumonia.
    Eur Heart J. 2020;41:2132.
    PubMed    
    
    
    
79. OLSHANSKY B
    The electrocardiogram: are we at the dawn of a new era?
    Eur Heart J. 2020;41:2000-2002.
    PubMed    
    
    
    May 2020
80. DE ROSA S, Spaccarotella C, Basso C, Calabro MP, et al
    Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era.
    Eur Heart J. 2020 May 15. pii: 5837572. doi: 10.1093.
    PubMed     Abstract available
    
    
    
81. CHIEFFO A, Stefanini GG, Price S, Barbato E, et al
    EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic.
    Eur Heart J. 2020;41:1839-1851.
    PubMed     Abstract available
    
    
    
82. METZLER B, Siostrzonek P, Binder RK, Bauer A, et al
    Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage.
    Eur Heart J. 2020;41:1852-1853.
    PubMed    
    
    
    
83. CAMPO G, Rapezzi C, Tavazzi L, Ferrari R, et al
    Priorities for Cath labs in the COVID-19 tsunami.
    Eur Heart J. 2020;41:1784-1785.
    PubMed    
    
    
    
84. SHAH R
    Accuracy of fractional flow reserve during acute myocardial infarction.
    Eur Heart J. 2020 May 8. pii: 5834910. doi: 10.1093.
    PubMed    
    
    
    
85. UEKI Y, Otsuka T, Windecker S, Raber L, et al
    ST-elevation myocardial infarction and pulmonary embolism in a patient with COVID-19 acute respiratory distress syndrome.
    Eur Heart J. 2020 May 6. pii: 5831090. doi: 10.1093.
    PubMed    
    
    
    
86. GAUDINO M, Freemantle N, Farkouh ME
    The conundrum of the treatment for left main coronary disease.
    Eur Heart J. 2020 May 5. pii: 5830808. doi: 10.1093.
    PubMed    
    
    
    
87. BJORNSTAD JL, Bendz B
    Periprocedural myocardial injury in the EXCEL trial.
    Eur Heart J. 2020;41:1703.
    PubMed    
    
    
    
88. HESS CN, Hiatt WR
    Progress in the prevention and treatment of atherosclerotic cardiovascular disease: two steps forward, one step back.
    Eur Heart J. 2020;41:1650-1652.
    PubMed    
    
    
    April 2020
89. DREXLER M, Elsner C, Gabelmann V, Gori T, et al
    Apple Watch detecting coronary ischaemia during chest pain episodes or an apple a day may keep myocardial infarction away.
    Eur Heart J. 2020 Apr 29. pii: 5826159. doi: 10.1093.
    PubMed    
    
    
    
90. HAN Y
    A treatment strategy for acute myocardial infarction and personal protection for medical staff during the COVID-19 epidemic: the Chinese experience.
    Eur Heart J. 2020 Apr 27. pii: 5825637. doi: 10.1093.
    PubMed    
    
    
    
91. ZULLO A, Lorenzetti R, Hassan C
    Is Escherichia coli involved in the myocardial infarction?
    Eur Heart J. 2020 Apr 16. pii: 5821041. doi: 10.1093.
    PubMed    
    
    
    
92. VIOLI F, Nocella C, Carnevale R
    Gut microbiota and myocardial infarction.
    Eur Heart J. 2020 Apr 16. pii: 5821053. doi: 10.1093.
    PubMed    
    
    
    
93. CHATTERJEE NA, Tikkanen JT, Panicker GK, Narula D, et al
    Simple electrocardiographic measures improve sudden arrhythmic death prediction in coronary disease.
    Eur Heart J. 2020 Apr 7. pii: 5817075. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2020
94. JING ZC, Zhu HD, Yan XW, Chai WZ, et al
    Recommendations from the Peking Union Medical College Hospital for the management of acute myocardial infarction during the COVID-19 outbreak.
    Eur Heart J. 2020 Mar 31. pii: 5813956. doi: 10.1093.
    PubMed    
    
    
    
95. STONE GW, Ben-Yehuda O, Sabik JF, Kappetein AP, et al
    Considerations for an optimal definition of procedural myocardial infarction.
    Eur Heart J. 2020 Mar 30. pii: 5813684. doi: 10.1093.
    PubMed    
    
    
    
96. BOHM M, Ferreira JP, Mahfoud F, Duarte K, et al
    Myocardial reperfusion reverses the J-curve association of cardiovascular risk and diastolic blood pressure in patients with left ventricular dysfunction and heart failure after myocardial infarction: insights from the EPHESUS trial.
    Eur Heart J. 2020 Mar 2. pii: 5771273. doi: 10.1093.
    PubMed     Abstract available
    
    
    
97. MESSERLI FH, Bangalore S, Messerli AW, Raber L, et al
    The muddy waters of the J-curve and coronary revascularization.
    Eur Heart J. 2020 Mar 2. pii: 5771269. doi: 10.1093.
    PubMed    
    
    
    
98. KIM WC, Sumaya W, Elkhateeb OE
    Fibroelastoma presenting with recurrent myocardial infarction and diagnosed with intracoronary imaging: a novel intracoronary image of fibroelastoma.
    Eur Heart J. 2020 Mar 2. pii: 6157022. doi: 10.1093.
    PubMed    
    
    
    
99. KLEBER ME, Delgado GE, Marz W
    LDL receptor traffic: in the fast lane.
    Eur Heart J. 2020;41:1054-1056.
    PubMed    
    
    
    February 2020
100. HARTIKAINEN TS, Sorensen NA, Haller PM, Gossling A, et al
     Clinical application of the 4th Universal Definition of Myocardial Infarction.
     Eur Heart J. 2020 Feb 20. pii: 5741381. doi: 10.1093.
     PubMed     Abstract available
     
     
     
101. ALLAHYARI A, Jernberg T, Hagstrom E, Leosdottir M, et al
     Application of the 2019 ESC/EAS dyslipidaemia guidelines to nationwide data of patients with a recent myocardial infarction: a simulation study.
     Eur Heart J. 2020 Feb 18. pii: 5739477. doi: 10.1093.
     PubMed     Abstract available
     
     
     
102. LABRECQUE JA, Kaufman JS, Huang JY
     Genetic instruments with too many strings: acknowledging pleiotropy and population structure in Mendelian randomization studies.
     Eur Heart J. 2020;41:892-893.
     PubMed    
     
     
     
103. SINNAEVE P, Van de Werf F
     Primary PCI and the indistinct 120 min time limit.
     Eur Heart J. 2020;41:867-869.
     PubMed    
     
     
     
104. RYMER JA, Granger CB
     Managing patients with ST-elevation myocardial infarction and multivessel disease: is the story complete?
     Eur Heart J. 2020 Feb 7. pii: 5729984. doi: 10.1093.
     PubMed    
     
     
     
105. RAMASAMY A, Bajaj R, Choudry FA, Pugliese F, et al
     Intravascular ultrasound-guided management of ST-elevation myocardial infarction in a patient with lung cancer and myocardial metastasis.
     Eur Heart J. 2020 Feb 7. pii: 5729982. doi: 10.1093.
     PubMed    
     
     
     
106. GIANNOPOULOS AA, Gaemperli O
     The power of myocardial blood flow reserve in personalizing management of patients with stable coronary artery disease. Is it time to move on from percentage of ischaemia?
     Eur Heart J. 2020;41:769-771.
     PubMed    
     
     
     January 2020
107. KALLISTRATOS MS, Poulimenos LE, Manolis AJ
     Beta blockers, calcium channel blockers, and long-acting nitrates for patients with stable angina and low blood pressure levels: should this recommendation be reconsidered?
     Eur Heart J. 2020;41:479.
     PubMed    
     
     
     
108. KNUUTI J, Wijns W, Funck-Brentano C
     Anti-ischaemic medication must be adapted to each patient's characteristics and preferences in patients with chronic coronary syndromes.
     Eur Heart J. 2020;41:480-481.
     PubMed    
     
     
     
109. SENGUPTA PP, Shrestha S, Zeb I
     Solving coronary risk: time to feed machines some calcium (score) supplements.
     Eur Heart J. 2020;41:368-370.
     PubMed    
     
     
     
110. POSS AM, Holland WL, Summers SA
     Risky lipids: refining the ceramide score that measures cardiovascular health.
     Eur Heart J. 2020;41:381-382.
     PubMed    
     
     
     
111. LUSCHER TF
     Chronic coronary syndromes: expanding the spectrum and natural history of ischaemic heart disease.
     Eur Heart J. 2020;41:333-336.
     PubMed    
     
     
     
112. IANNACCONE M, Brilakis ES, Boccuzzi GG
     An App for complex PCI solutions.
     Eur Heart J. 2020;41:342-344.
     PubMed    
     
     
     
113. AL'AREF SJ, Maliakal G, Singh G, van Rosendael AR, et al
     Machine learning of clinical variables and coronary artery calcium scoring for the prediction of obstructive coronary artery disease on coronary computed tomography angiography: analysis from the CONFIRM registry.
     Eur Heart J. 2020;41:359-367.
     PubMed     Abstract available
     
     
     
114. KNUUTI J, Wijns W, Saraste A, Capodanno D, et al
     2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.
     Eur Heart J. 2020;41:407-477.
     PubMed    
     
     
     
115. SORBETS E, Fox KM, Elbez Y, Danchin N, et al
     Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry.
     Eur Heart J. 2020;41:347-356.
     PubMed     Abstract available
     
     
     
116. PRATI F, Romagnoli E, Gatto L, La Manna A, et al
     Relationship between coronary plaque morphology of the left anterior descending artery and 12 months clinical outcome: the CLIMA study.
     Eur Heart J. 2020;41:383-391.
     PubMed     Abstract available
     
     
     
117. HILVO M, Meikle PJ, Pedersen ER, Tell GS, et al
     Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients.
     Eur Heart J. 2020;41:371-380.
     PubMed     Abstract available
     
     
     
118. ALI ZA, McEntegart M, Hill JM, Spratt JC, et al
     Intravascular lithotripsy for treatment of stent underexpansion secondary to severe coronary calcification.
     Eur Heart J. 2020;41:485-486.
     PubMed    
     
     
     
119. LEE HS, Chang M, Piccinelli M, Koo BK, et al
     Complete regression of coronary atherosclerosis.
     Eur Heart J. 2020;41:332.
     PubMed    
     
     
     
120. BAUMBACH A, Bourantas CV, Serruys PW, Wijns W, et al
     The year in cardiology: coronary interventions.
     Eur Heart J. 2020 Jan 6. pii: 5694318. doi: 10.1093.
     PubMed    
     
     
     
121. CARNEVALE R, Sciarretta S, Valenti V, di Nonno F, et al
     Low-grade endotoxaemia enhances artery thrombus growth via Toll-like receptor 4: implication for myocardial infarction.
     Eur Heart J. 2020 Jan 3. pii: 5695525. doi: 10.1093.
     PubMed     Abstract available
     
     
     December 2019
122. PAVASINI R, Biscaglia S, Barbato E, Tebaldi M, et al
     Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials.
     Eur Heart J. 2019 Dec 31. pii: 5692630. doi: 10.1093.
     PubMed     Abstract available
     
     
     
123. LANCINI D, Shetty R
     Tension pneumothorax: a Brugada phenocopy and ST-elevation myocardial infarction mimic.
     Eur Heart J. 2019 Dec 28. pii: 5688935. doi: 10.1093.
     PubMed    
     
     
     
124. WELSH RC
     Applying evidence-based antiplatelet therapy in patients following a myocardial infarction without percutaneous coronary revascularization.
     Eur Heart J. 2019 Dec 23. pii: 5686009. doi: 10.1093.
     PubMed    
     
     
     
125. ROEVER L, Tse G, Versaci F, Biondi-Zoccai G, et al
     Admission glucagon-like peptide-1 levels in acute myocardial infarction: is this a new biomarker of cardiovascular risk?
     Eur Heart J. 2019 Dec 13. pii: 5675546. doi: 10.1093.
     PubMed    
     
     
     
126. KALLA M, Hao G, Tapoulal N, Tomek J, et al
     The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockade.
     Eur Heart J. 2019 Dec 13. pii: 5675548. doi: 10.1093.
     PubMed     Abstract available
     
     
     
127. FURTADO RHM, Nicolau JC, Magnani G, Im K, et al
     Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54.
     Eur Heart J. 2019 Dec 7. pii: 5663567. doi: 10.1093.
     PubMed     Abstract available
     
     
     
128. BHARADWAJ A, Potts J, Mohamed MO, Parwani P, et al
     Acute myocardial infarction treatments and outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA.
     Eur Heart J. 2019 Dec 4. pii: 5652220. doi: 10.1093.
     PubMed     Abstract available
     
     
     
129. LOPEZ-JIMENEZ F, Gersh BJ
     Secondary prevention after coronary artery bypass grafting saves lives: a golden opportunity often wasted.
     Eur Heart J. 2019 Dec 4. pii: 5651910. doi: 10.1093.
     PubMed    
     
     
     November 2019
130. LOPES RD, Hong H, Alexander JH
     Antithrombotic therapy after acute coronary syndrome and/or percutaneous coronary intervention in atrial fibrillation: finding the sweet spot.
     Eur Heart J. 2019 Nov 27. pii: 5644218. doi: 10.1093.
     PubMed    
     
     
     
131. EBERHARD M, Hermann M, Stahli BE, Manka R, et al
     Amphetamine-induced coronary artery dissection and massive aortic valve thrombus.
     Eur Heart J. 2019 Nov 25. pii: 5640488. doi: 10.1093.
     PubMed    
     
     
     
132. LUSCHER TF
     Optimizing heart failure management: anticoagulation, diuretic withdrawal, iron substitution, and novel inotropes.
     Eur Heart J. 2019;40:3579-3582.
     PubMed    
     
     
     October 2019
133. GARGIULO G, Goette A, Tijssen J, Eckardt L, et al
     Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based rand
     Eur Heart J. 2019 Oct 25. pii: 5607287. doi: 10.1093.
     PubMed     Abstract available
     
     
     
134. RIMBERT A, Dalila N, Wolters JC, Huijkman N, et al
     A common variant in CCDC93 protects against myocardial infarction and cardiovascular mortality by regulating endosomal trafficking of low-density lipoprotein receptor.
     Eur Heart J. 2019 Oct 19. pii: 5599853. doi: 10.1093.
     PubMed     Abstract available
     
     
     
135. KAHLES F, Ruckbeil MV, Mertens RW, Foldenauer AC, et al
     Glucagon-like peptide 1 levels predict cardiovascular risk in patients with acute myocardial infarction.
     Eur Heart J. 2019 Oct 16. pii: 5588525. doi: 10.1093.
     PubMed     Abstract available
     
     
     
136. IBANEZ B
     And fibrinolysis became pharmacoinvasive.
     Eur Heart J. 2019 Oct 12. pii: 5586502. doi: 10.1093.
     PubMed    
     
     
     September 2019
137. DANCHIN N, Popovic B, Puymirat E, Goldstein P, et al
     Five-year outcomes following timely primary percutaneous intervention, late primary percutaneous intervention, or a pharmaco-invasive strategy in ST-segment elevation myocardial infarction: the FAST-MI programme.
     Eur Heart J. 2019 Sep 20. pii: 5572227. doi: 10.1093.
     PubMed     Abstract available
     
     
     
138. THRANE PG, Kristensen SD, Olesen KKW, Mortensen LS, et al
     16-year follow-up of the Danish Acute Myocardial Infarction 2 (DANAMI-2) trial: primary percutaneous coronary intervention vs. fibrinolysis in ST-segment elevation myocardial infarction.
     Eur Heart J. 2019 Sep 2. pii: 5554441. doi: 10.1093.
     PubMed     Abstract available
     
     
     
139. MUKHERJEE D
     Tailoring strategies to optimize ischaemic benefit vs. bleeding risk in individuals post-myocardial infarction.
     Eur Heart J. 2019 Sep 1. pii: 5555736. doi: 10.1093.
     PubMed    
     
     
     
140. SIMONSSON M, Wallentin L, Alfredsson J, Erlinge D, et al
     Temporal trends in bleeding events in acute myocardial infarction: insights from the SWEDEHEART registry.
     Eur Heart J. 2019 Sep 1. pii: 5554428. doi: 10.1093.
     PubMed     Abstract available
     
     
     August 2019
141. TAYAL B, Fruelund P, Sogaard P, Riahi S, et al
     Incidence of heart failure after pacemaker implantation: a nationwide Danish Registry-based follow-up study.
     Eur Heart J. 2019 Aug 26. pii: 5554632. doi: 10.1093.
     PubMed     Abstract available
     
     
     
142. LUSCHER TF
     Refining percutaneous coronary intervention: intracoronary imaging, haemodynamics, P2Y12 antagonists, and public outcomes reporting.
     Eur Heart J. 2019;40:2549-2552.
     PubMed    
     
     
     
143. SERRUYS PW, Takahashi K, Chichareon P, Kogame N, et al
     Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial.
     Eur Heart J. 2019;40:2595-2604.
     PubMed     Abstract available
     
     
     
144. CREA F, Montone RA, Niccoli G
     Myocardial infarction with non-obstructive coronary atherosclerosis: dealing with pears and apples.
     Eur Heart J. 2019 Aug 3. pii: 5543490. doi: 10.1093.
     PubMed    
     
     
     
145. MAGGIONI AP, Andreotti F
     Stroke prevention by low-dose anticoagulation in patients with heart failure and sinus rhythm: is it worth the effort?
     Eur Heart J. 2019 Aug 1. pii: 5542639. doi: 10.1093.
     PubMed    
     
     
     July 2019
146. ODER D, Topp MS, Nordbeck P
     Coronary B-cell lymphoma infiltration causing myocardial infarction.
     Eur Heart J. 2019 Jul 31. pii: 5542062. doi: 10.1093.
     PubMed    
     
     
     
147. FRANGOGIANNIS NG
     S100A8/A9 as a therapeutic target in myocardial infarction: cellular mechanisms, molecular interactions, and translational challenges.
     Eur Heart J. 2019 Jul 23. pii: 5537337. doi: 10.1093.
     PubMed    
     
     
     
148. MARINKOVIC G, Grauen Larsen H, Yndigegn T, Szabo IA, et al
     Inhibition of pro-inflammatory myeloid cell responses by short-term S100A9 blockade improves cardiac function after myocardial infarction.
     Eur Heart J. 2019 Jul 10. pii: 5530698. doi: 10.1093.
     PubMed     Abstract available
     
     
     
149. THIELE H, Ohman EM, de Waha-Thiele S, Zeymer U, et al
     Management of cardiogenic shock complicating myocardial infarction: an update 2019.
     Eur Heart J. 2019 Jul 4. pii: 5528526. doi: 10.1093.
     PubMed     Abstract available
     
     
     June 2019
150. 
     Corrigendum to: Ephemeral Coronary Heart Disease.
     Eur Heart J. 2019 Jun 29. pii: 5530690. doi: 10.1093.
     PubMed    
     
     
     
151. THYGESEN K, Jaffe AS
     Should myocardial infarction type 2 be regarded as two separate entities?
     Eur Heart J. 2019 Jun 26. pii: 5523696. doi: 10.1093.
     PubMed    
     
     
     
152. MEHRA MR, Vaduganathan M, Fu M, Ferreira JP, et al
     A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial
     Eur Heart J. 2019 Jun 25. pii: 5522950. doi: 10.1093.
     PubMed     Abstract available
     
     
     
153. MESSERLI FH
     Ephemeral Coronary Heart Disease.
     Eur Heart J. 2019;40:1906-1908.
     PubMed    
     
     
     
154. DREYER RP, Tavella R, Curtis JP, Wang Y, et al
     Myocardial infarction with non-obstructive coronary arteries as compared with myocardial infarction and obstructive coronary disease: outcomes in a Medicare population.
     Eur Heart J. 2019 Jun 21. pii: 5521361. doi: 10.1093.
     PubMed     Abstract available
     
     
     
155. WHITE HD
     Adjunctive antithrombotic therapy with primary percutaneous coronary intervention in ST elevation myocardial infarction: ATOLL in perspective.
     Eur Heart J. 2019;40:e4-e7.
     PubMed    
     
     
     
156. ZENG L, Ntalla I, Kessler T, Kastrati A, et al
     Genetically modulated educational attainment and coronary disease risk.
     Eur Heart J. 2019 Jun 6. pii: 5512096. doi: 10.1093.
     PubMed     Abstract available
     
     
     
157. LI Z, Solomonidis EG, Meloni M, Taylor RS, et al
     Single-cell transcriptome analyses reveal novel targets modulating cardiac neovascularization by resident endothelial cells following myocardial infarction.
     Eur Heart J. 2019 Jun 4. pii: 5510786. doi: 10.1093.
     PubMed     Abstract available
     
     
     
158. ROHDE D, Nahrendorf M
     Clonal and diverse: revisiting cardiac endothelial cells after myocardial infarction.
     Eur Heart J. 2019 Jun 4. pii: 5510784. doi: 10.1093.
     PubMed    
     
     
     
159. GENTILLE LORENTE DI
     Coconut atrium: a rare entity to cause pulmonary hypertension.
     Eur Heart J. 2019 Jun 4. pii: 5510776. doi: 10.1093.
     PubMed    
     
     
     May 2019
160. LEMKES JS, Janssens GN, van Royen N
     ST-resolution and spontaneous reperfusion in patients with transient ST-segment elevation myocardial infarction.
     Eur Heart J. 2019 May 29. pii: 5506052. doi: 10.1093.
     PubMed    
     
     
     
161. WHITE HD, Steg PG, Szarek M, Bhatt DL, et al
     Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial.
     Eur Heart J. 2019 May 23. pii: 5497814. doi: 10.1093.
     PubMed     Abstract available
     
     
     
162. URBAN P, Mehran R, Colleran R, Angiolillo DJ, et al
     Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk.
     Eur Heart J. 2019 May 22. pii: 5492739. doi: 10.1093.
     PubMed     Abstract available
     
     
     
163. NISHI T, Funabashi N, Fujimoto Y, Kobayashi Y, et al
     Simultaneous anterior and inferior myocardial infarction in a patient with a single coronary artery anomaly.
     Eur Heart J. 2019 May 3. pii: 5485104. doi: 10.1093.
     PubMed    
     
     
     
164. GATZOULIS KA, Tsiachris D, Arsenos P, Antoniou CK, et al
     Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study.
     Eur Heart J. 2019 May 3. pii: 5485105. doi: 10.1093.
     PubMed     Abstract available
     
     
     April 2019
165. HU C, Tkebuchava T, Hu D
     Managing acute myocardial infarction in China.
     Eur Heart J. 2019;40:1179-1181.
     PubMed    
     
     
     
166. JONES DA, Rathod KS, Koganti S, Lim P, et al
     The association between the public reporting of individual operator outcomes with patient profiles, procedural management, and mortality after percutaneous coronary intervention: an observational study from the Pan-London PCI (BCIS) Registry using an
     Eur Heart J. 2019 Apr 10. pii: 5443278. doi: 10.1093.
     PubMed     Abstract available
     
     
     
167. MEHRAN R, Kalkman DN, Angiolillo DJ
     Atrial fibrillation, with ACS and PCI: walking a tightrope.
     Eur Heart J. 2019 Apr 8. pii: 5431179. doi: 10.1093.
     PubMed    
     
     
     March 2019
168. BEN-YEHUDA O, Chen S, Redfors B, McAndrew T, et al
     Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial.
     Eur Heart J. 2019 Mar 28. pii: 5421317. doi: 10.1093.
     PubMed     Abstract available
     
     
     
169. GRABHER F, Hamm W, Massberg S, Orban M, et al
     Uncommon cause of progressive dyspnoea 12 years after coronary artery bypass surgery.
     Eur Heart J. 2019 Mar 12. pii: 5377349. doi: 10.1093.
     PubMed    
     
     
     
170. HERRING N, Tapoulal N, Kalla M, Ye X, et al
     Neuropeptide-Y causes coronary microvascular constriction and is associated with reduced ejection fraction following ST-elevation myocardial infarction.
     Eur Heart J. 2019 Mar 11. pii: 5374846. doi: 10.1093.
     PubMed     Abstract available
     
     
     
171. CHEN K, Breitner S, Wolf K, Hampel R, et al
     Temporal variations in the triggering of myocardial infarction by air temperature in Augsburg, Germany, 1987-2014.
     Eur Heart J. 2019 Mar 11. pii: 5374842. doi: 10.1093.
     PubMed     Abstract available
     
     
     
172. YOSHIDA R, Takagi K, Morita Y, Morishima I, et al
     Incidentally discovered left ventricular pseudoaneurysm after silent myocardial infarction occurred in a young woman with peritoneal dialysis.
     Eur Heart J. 2019 Mar 11. pii: 5374728. doi: 10.1093.
     PubMed    
     
     
     
173. SEHESTED TSG, Carlson N, Hansen PW, Gerds TA, et al
     Reduced risk of gastrointestinal bleeding associated with proton pump inhibitor therapy in patients treated with dual antiplatelet therapy after myocardial infarction.
     Eur Heart J. 2019 Mar 9. pii: 5372329. doi: 10.1093.
     PubMed     Abstract available
     
     
     
174. REDFORS B, Dworeck C, Haraldsson I, Angeras O, et al
     Pretreatment with P2Y12 receptor antagonists in ST-elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry.
     Eur Heart J. 2019 Mar 9. pii: 5372330. doi: 10.1093.
     PubMed     Abstract available
     
     
     
175. RABER L, Yamaji K, Kelbaek H, Engstrom T, et al
     Five-year clinical outcomes and intracoronary imaging findings of the COMFORTABLE AMI trial: randomized comparison of biodegradable polymer-based biolimus-eluting stents with bare-metal stents in patients with acute ST-segment elevation myocardial inf
     Eur Heart J. 2019 Mar 9. pii: 5372331. doi: 10.1093.
     PubMed     Abstract available
     
     
     February 2019
176. HECHT HS, Shaw L, Chandrashekhar YS, Bax JJ, et al
     Should NICE guidelines be universally accepted for the evaluation of stable coronary disease? A debate.
     Eur Heart J. 2019 Feb 27. pii: 5366197. doi: 10.1093.
     PubMed     Abstract available
     
     
     
177. OLDGREN J, Steg PG, Hohnloser SH, Lip GYH, et al
     Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial.
     Eur Heart J. 2019 Feb 21. pii: 5359476. doi: 10.1093.
     PubMed     Abstract available
     
     
     
178. WITASSEK F, Radovanovic D, Erne P, Puhan M, et al
     Mortality with antidepressants after acute MI: Antidepressant use after acute myocardial infarction (MI) is associated with an increased mortality 1 year after discharge from Swiss hospitals.
     Eur Heart J. 2019;40:410.
     PubMed    
     
     
     January 2019
179. CHEN S, Stone GW
     Circadian influences, time of hospitalization, and prognosis in acute myocardial infarction.
     Eur Heart J. 2019 Jan 30. pii: 5304404. doi: 10.1093.
     PubMed    
     
     
     
180. WU J, Hall M, Dondo TB, Wilkinson C, et al
     Association between time of hospitalization with acute myocardial infarction and in-hospital mortality.
     Eur Heart J. 2019 Jan 29. pii: 5301310. doi: 10.1093.
     PubMed     Abstract available
     
     
     
181. VACCARINO V, Badimon L, Bremner JD, Cenko E, et al
     Depression and coronary heart disease: 2018 ESC position paper of the working group of coronary pathophysiology and microcirculation developed under the auspices of the ESC Committee for Practice Guidelines.
     Eur Heart J. 2019 Jan 28. pii: 5303703. doi: 10.1093.
     PubMed    
     
     
     
182. KHAN AA, Lip GYH
     Non-vitamin K antagonist oral anticoagulants beyond atrial fibrillation: what did we learn from COMPASS and COMMANDER-HF?
     Eur Heart J. 2019 Jan 21. pii: 5298544. doi: 10.1093.
     PubMed    
     
     
     
183. THYGESEN K
     'Ten Commandments' for the Fourth Universal Definition of Myocardial Infarction 2018.
     Eur Heart J. 2019;40:226.
     PubMed    
     
     
     
184. CREA F, Bairey Merz CN, Beltrame JF, Berry C, et al
     Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization.
     Eur Heart J. 2019 Jan 4. pii: 5273474. doi: 10.1093.
     PubMed     Abstract available
     
     
     
185. DUDEK D, Dziewierz A, Stone G, Wijns W, et al
     The year in cardiology 2018: coronary interventions.
     Eur Heart J. 2019 Jan 2. pii: 5265297. doi: 10.1093.
     PubMed    
     
     
     December 2018
186. ZIMMERMANN FM, Omerovic E, Fournier S, Kelbaek H, et al
     Fractional flow reserve-guided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions: meta-analysis of individual patient data.
     Eur Heart J. 2018 Dec 28. pii: 5265290. doi: 10.1093.
     PubMed     Abstract available
     
     
     
187. LUSCHER TF
     Personalized approaches to heart failure: age, acute presentation, and comorbidities.
     Eur Heart J. 2018;39:4223-4226.
     PubMed    
     
     
     
188. RESOR CD, Bhatt DL
     Bioresorbable vascular scaffolds in acute myocardial infarction: non-inferior or not enough data?
     Eur Heart J. 2018 Dec 18. pii: 5251899. doi: 10.1093.
     PubMed    
     
     
     
189. BYRNE RA, Alfonso F, Schneider S, Maeng M, et al
     Prospective, randomized trial of bioresorbable scaffolds vs. everolimus-eluting stents in patients undergoing coronary stenting for myocardial infarction: the Intracoronary Scaffold Assessment a Randomized evaluation of Absorb in Myocardial Infarction
     Eur Heart J. 2018 Dec 5. pii: 5231946. doi: 10.1093.
     PubMed     Abstract available
     
     
     November 2018
190. POTTS JE, Iliescu CA, Lopez Mattei JC, Martinez SC, et al
     Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States.
     Eur Heart J. 2018 Nov 30. pii: 5221009. doi: 10.1093.
     PubMed     Abstract available
     
     
     
191. SHARMA S, Malhotra A
     Exercise testing and coronary disease: pushing fitness to higher peaks.
     Eur Heart J. 2018 Nov 29. pii: 5193507. doi: 10.1093.
     PubMed    
     
     
     
192. LETNES JM, Dalen H, Vesterbekkmo EK, Wisloff U, et al
     Peak oxygen uptake and incident coronary heart disease in a healthy population: the HUNT Fitness Study.
     Eur Heart J. 2018 Nov 29. pii: 5193503. doi: 10.1093.
     PubMed     Abstract available
     
     
     
193. XIN Y, Chen X, Hu W
     Oxygen therapy in ST-elevation myocardial infarction.
     Eur Heart J. 2018 Nov 28. pii: 5212709. doi: 10.1093.
     PubMed    
     
     
     
194. POLIMENI A, Spaccarotella C, Mongiardo A, Indolfi C, et al
     Myocardial infarction after dog bite.
     Eur Heart J. 2018 Nov 28. pii: 5212711. doi: 10.1093.
     PubMed    
     
     
     
195. BERGMARK BA, Faxon DP
     Transient ST-segment myocardial infarction: a new category of high risk acute coronary syndrome?
     Eur Heart J. 2018 Nov 15. pii: 5184544. doi: 10.1093.
     PubMed    
     
     
     
196. THYGESEN K
     What's new in the Fourth Universal Definition of Myocardial infarction?
     Eur Heart J. 2018;39:3757-3758.
     PubMed    
     
     
     
197. ELNABAWI YA, Dey AK, Mehta NN
     Emerging Applications of Coronary CT Angiography in Coronary Heart Disease: Getting Better with Time.
     Eur Heart J. 2018;39:3682-3684.
     PubMed    
     
     
     October 2018
198. FARAG M, Spinthakis N, Gue YX, Srinivasan M, et al
     Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study.
     Eur Heart J. 2018 Oct 30. pii: 5149701. doi: 10.1093.
     PubMed     Abstract available
     
     
     
199. LEMKES JS, Janssens GN, van der Hoeven NW, van de Ven PM, et al
     Timing of revascularization in patients with transient ST-segment elevation myocardial infarction: a randomized clinical trial.
     Eur Heart J. 2018 Oct 26. pii: 5145843. doi: 10.1093.
     PubMed     Abstract available
     
     
     
200. KALKMAN DN, Aquino M, Claessen BE, Baber U, et al
     Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions.
     Eur Heart J. 2018 Oct 25. pii: 5144689. doi: 10.1093.
     PubMed     Abstract available
     
     
     
201. HERITIER H, Vienneau D, Foraster M, Eze IC, et al
     A systematic analysis of mutual effects of transportation noise and air pollution exposure on myocardial infarction mortality: a nationwide cohort study in Switzerland.
     Eur Heart J. 2018 Oct 24. pii: 5144026. doi: 10.1093.
     PubMed     Abstract available
     
     
     
202. WALLENTIN L
     Different perspectives on outcomes in patients with non-ST-elevation myocardial infarction when observed in clinical trials and in real life.
     Eur Heart J. 2018 Oct 17. pii: 5137113. doi: 10.1093.
     PubMed    
     
     
     September 2018
203. SZUMMER K, Wallentin L, Lindhagen L, Alfredsson J, et al
     Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014.
     Eur Heart J. 2018 Sep 19. pii: 5103432. doi: 10.1093.
     PubMed     Abstract available
     
     
     
204. STONE GW, Genereux P, Harrington RA, White HD, et al
     Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHA
     Eur Heart J. 2018 Sep 9. pii: 5093357. doi: 10.1093.
     PubMed     Abstract available
     
     
     
205. HALL M, Bebb OJ, Dondo TB, Yan AT, et al
     Guideline-indicated treatments and diagnostics, GRACE risk score, and survival for non-ST elevation myocardial infarction.
     Eur Heart J. 2018 Sep 7. pii: 5092654. doi: 10.1093.
     PubMed     Abstract available
     
     
     
206. MONTONE RA, Niccoli G, Lanza GA, Crea F, et al
     Reconsidering aetiologies of type 2 myocardial infarction: when a classification is a simplistic approach for a complex reality.
     Eur Heart J. 2018 Sep 6. pii: 5091846. doi: 10.1093.
     PubMed    
     
     
     
207. NESTELBERGER T, Boeddinghaus J, Mueller C
     Type 2 myocardial infarction.
     Eur Heart J. 2018 Sep 6. pii: 5091844. doi: 10.1093.
     PubMed    
     
     
     August 2018
208. BOEDDINGHAUS J, Nestelberger T, Twerenbold R, Neumann JT, et al
     Impact of age on the performance of the ESC 0/1h-algorithms for early diagnosis of myocardial infarction.
     Eur Heart J. 2018 Aug 29. pii: 5086724. doi: 10.1093.
     PubMed     Abstract available
     
     
     
209. THYGESEN K, Alpert JS, Jaffe AS, Chaitman BR, et al
     Fourth universal definition of myocardial infarction (2018).
     Eur Heart J. 2018 Aug 25. pii: 5079081. doi: 10.1093.
     PubMed    
     
     
     
210. WINDECKER S, Neumann FJ, Juni P, Sousa-Uva M, et al
     Considerations for the choice between coronary artery bypass grafting and percutaneous coronary intervention as revascularization strategies in major categories of patients with stable multivessel coronary artery disease: an accompanying article of th
     Eur Heart J. 2018 Aug 25. pii: 5077827. doi: 10.1093.
     PubMed    
     
     
     
211. SHIMONO H, Kajiya T, Atsuchi Y, Atsuchi N, et al
     Giant left ventricular pseudo-aneurysm after posterior myocardial infarction.
     Eur Heart J. 2018 Aug 21. pii: 5077320. doi: 10.1093.
     PubMed    
     
     
     
212. SHEHATA N, Mistry N, da Costa BR, Pereira TV, et al
     Restrictive compared with liberal red cell transfusion strategies in cardiac surgery: a meta-analysis.
     Eur Heart J. 2018 Aug 10. pii: 5070413. doi: 10.1093.
     PubMed     Abstract available
     
     
     
213. POLOVINA M, Hindricks G, Maggioni A, Piepoli M, et al
     Association of metabolic syndrome with non-thromboembolic adverse cardiac outcomes in patients with atrial fibrillation.
     Eur Heart J. 2018 Aug 7. pii: 5067645. doi: 10.1093.
     PubMed     Abstract available
     
     
     
214. O'SHAUGHNESSY MM, Liu S, Montez-Rath ME, Lafayette RA, et al
     Cause of kidney disease and cardiovascular events in a national cohort of US patients with end-stage renal disease on dialysis: a retrospective analysis.
     Eur Heart J. 2018 Aug 2. pii: 5064050. doi: 10.1093.
     PubMed     Abstract available
     
     
     July 2018
215. VARENNE O, Sinnaeve PR
     De-escalation of antiplatelet treatment after percutaneous coronary interventions for acute coronary syndromes: is less more?
     Eur Heart J. 2018 Jul 24. pii: 5057993. doi: 10.1093.
     PubMed    
     
     
     
216. LUSCHER TF
     Performance of modern stents in stable and acute coronary disease.
     Eur Heart J. 2018;39:2435-2438.
     PubMed    
     
     
     June 2018
217. SAITO S, Krucoff MW, Nakamura S, Mehran R, et al
     Japan-United States of America Harmonized Assessment by Randomized Multicentre Study of OrbusNEich's Combo StEnt (Japan-USA HARMONEE) study: primary results of the pivotal registration study of combined endothelial progenitor cell capture and drug-elu
     Eur Heart J. 2018 Jun 21. pii: 5042208. doi: 10.1093.
     PubMed     Abstract available
     
     
     
218. HOFMANN R, Witt N, Lagerqvist B, Jernberg T, et al
     Oxygen therapy in ST-elevation myocardial infarction.
     Eur Heart J. 2018 Jun 14. pii: 5037999. doi: 10.1093.
     PubMed     Abstract available
     
     
     
219. GARCIA-GARCIA HM, McFadden EP, Farb A, Mehran R, et al
     Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document.
     Eur Heart J. 2018;39:2192-2207.
     PubMed     Abstract available
     
     
     May 2018
220. MONTONE RA, Niccoli G, Lanza GA, Crea F, et al
     Personalized treatment of myocardial infarction and non-obstructive coronary arteries: an unmet need in a high-risk population.
     Eur Heart J. 2018 May 29. pii: 5020746. doi: 10.1093.
     PubMed    
     
     
     
221. IBANEZ B, Halvorsen S, Roffi M, Bueno H, et al
     Integrating the results of the CULPRIT-SHOCK trial in the 2017 ESC ST-elevation myocardial infarction guidelines: viewpoint of the task force.
     Eur Heart J. 2018 May 29. pii: 5020748. doi: 10.1093.
     PubMed    
     
     
     
222. JANSSENS SP, Bogaert J, Zalewski J, Toth A, et al
     Nitric oxide for inhalation in ST-elevation myocardial infarction (NOMI): a multicentre, double-blind, randomized controlled trial.
     Eur Heart J. 2018 May 24. pii: 5003325. doi: 10.1093.
     PubMed     Abstract available
     
     
     
223. RABER L, Mintz GS, Koskinas KC, Johnson TW, et al
     Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions: Endorsed by the Chinese Society of Cardiology.
     Eur Heart J. 2018 May 22. pii: 5001185. doi: 10.1093.
     PubMed     Abstract available
     
     
     April 2018
224. MAHMOUD KD, Jolly SS, James S, Dzavik V, et al
     Clinical impact of direct stenting and interaction with thrombus aspiration in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: Thrombectomy Trialists Collaboration.
     Eur Heart J. 2018 Apr 21. pii: 4975836. doi: 10.1093.
     PubMed     Abstract available
     
     
     March 2018
225. WALDMANN V, Bougouin W, Karam N, Dumas F, et al
     Characteristics and clinical assessment of unexplained sudden cardiac arrest in the real-world setting: focus on idiopathic ventricular fibrillation.
     Eur Heart J. 2018 Mar 16. pii: 4939309. doi: 10.1093.
     PubMed     Abstract available
     
     
     
226. AUFFRET V, Cottin Y, Leurent G, Gilard M, et al
     Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score.
     Eur Heart J. 2018 Mar 15. pii: 4938779. doi: 10.1093.
     PubMed     Abstract available
     
     
     
227. DAI J, Xing L, Jia H, Zhu Y, et al
     In vivo predictors of plaque erosion in patients with ST-segment elevation myocardial infarction: a clinical, angiographical, and intravascular optical coherence tomography study.
     Eur Heart J. 2018 Mar 13. pii: 4934156. doi: 10.1093.
     PubMed     Abstract available
     
     
     February 2018
228. THYGESEN K, Jaffe AS
     The prognostic impact of periprocedural myocardial infarction and injury.
     Eur Heart J. 2018 Feb 26. pii: 4911112. doi: 10.1093.
     PubMed    
     
     
     
229. QAYYUM F, Lauridsen BK, Frikke-Schmidt R, Kofoed KF, et al
     Genetic variants in CYP7A1 and risk of myocardial infarction and symptomatic gallstone disease.
     Eur Heart J. 2018 Feb 23. pii: 4907930. doi: 10.1093.
     PubMed     Abstract available
     
     
     
230. 
     euro6.5 million award to study impact of ECMO on myocardial infarction patients.
     Eur Heart J. 2018;39:649.
     PubMed    
     
     
     
231. WIJNS W, Naber CK
     Reperfusion delay in patients with high-risk ST-segment elevation myocardial infarction: every minute counts, much more than suspected.
     Eur Heart J. 2018 Feb 14. pii: 4855285. doi: 10.1093.
     PubMed    
     
     
     
232. SCHOLZ KH, Maier SKG, Maier LS, Lengenfelder B, et al
     Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial.
     Eur Heart J. 2018 Feb 14. pii: 4855284. doi: 10.1093.
     PubMed     Abstract available
     
     
     January 2018
233. BERGMARK BA, Scirica BM, Steg PG, Fanola CL, et al
     Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk.
     Eur Heart J. 2018 Jan 31. pii: 4831245. doi: 10.1093.
     PubMed     Abstract available
     
     
     
234. ZEITOUNI M, Silvain J, Guedeney P, Kerneis M, et al
     Periprocedural myocardial infarction and injury in elective coronary stenting.
     Eur Heart J. 2018 Jan 20. pii: 4815728. doi: 10.1093.
     PubMed     Abstract available
     
     
     
235. MEHLUM MH, Liestol K, Kjeldsen SE, Julius S, et al
     Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks.
     Eur Heart J. 2018 Jan 20. pii: 4815726. doi: 10.1093.
     PubMed     Abstract available
     
     
     
236. LUSCHER TF
     ST-segment elevation myocardial infarction: the new ESC Guidelines.
     Eur Heart J. 2018;39:75-78.
     PubMed    
     
     
     
237. KIM K, Park SM, Lee K
     Weight gain after smoking cessation does not modify its protective effect on myocardial infarction and stroke: evidence from a cohort study of men.
     Eur Heart J. 2018 Jan 6. pii: 4791953. doi: 10.1093.
     PubMed     Abstract available
     
     
     December 2017
238. KOENIG T, Sedding DG, Wester HJ, Derlin T, et al
     Seeing the unseen: post-infarction inflammation in an isolated right ventricular myocardial infarction visualized by combined cardiac magnetic resonance imaging and chemokine receptor CXCR4-targeted molecular imaging.
     Eur Heart J. 2017 Dec 27. pii: 4780241. doi: 10.1093.
     PubMed    
     
     
     
239. MONTONE RA, Niccoli G, Fracassi F, Russo M, et al
     Patients with acute myocardial infarction and non-obstructive coronary arteries: safety and prognostic relevance of invasive coronary provocative tests.
     Eur Heart J. 2017 Dec 8. pii: 4710061. doi: 10.1093.
     PubMed     Abstract available
     
     
     November 2017
240. KUBO T, Shinke T, Okamura T, Hibi K, et al
     Optical frequency domain imaging vs. intravascular ultrasound in percutaneous coronary intervention (OPINION trial): one-year angiographic and clinical results.
     Eur Heart J. 2017;38:3139-3147.
     PubMed     Abstract available
     
     
     
241. LUSCHER TF
     Optimizing percutaneous coronary interventions: Heart Team, SYNTAX II Score, physiology and imaging guidance, modern stents, and guideline-based medication.
     Eur Heart J. 2017;38:3109-3113.
     PubMed    
     
     
     October 2017
242. KIM MK, Han K, Kim HS, Park YM, et al
     Cholesterol variability and the risk of mortality, myocardial infarction, and stroke: a nationwide population-based study.
     Eur Heart J. 2017 Oct 21. doi: 10.1093.
     PubMed     Abstract available
     
     
     
243. THYGESEN K, Jaffe AS
     Detecting myocardial infarction type 2: targetting the right patients.
     Eur Heart J. 2017 Oct 5. doi: 10.1093.
     PubMed    
     
     
     
244. MANIWA N, Fujino M, Nakai M, Nishimura K, et al
     Anticoagulation combined with antiplatelet therapy in patients with left ventricular thrombus after first acute myocardial infarction.
     Eur Heart J. 2017 Oct 3. doi: 10.1093.
     PubMed     Abstract available
     
     
     September 2017
245. LEU HB, Chang HH, Lin SM, Chen YH, et al
     Double trouble for transcatheter aortic valve implantation: a patient with no vascular access and high-risk features for bilateral coronary obstruction.
     Eur Heart J. 2017;38:2787.
     PubMed    
     
     
     
246. KIVIMAKI M, Nyberg ST, Batty GD, Kawachi I, et al
     Long working hours as a risk factor for atrial fibrillation: a multi-cohort study.
     Eur Heart J. 2017;38:2621-2628.
     PubMed     Abstract available
     
     
     August 2017
247. KOJIMA S, Michikawa T, Ueda K, Sakamoto T, et al
     Asian dust exposure triggers acute myocardial infarction.
     Eur Heart J. 2017 Aug 29. doi: 10.1093.
     PubMed     Abstract available
     
     
     
248. SZUMMER K, Wallentin L, Lindhagen L, Alfredsson J, et al
     Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014.
     Eur Heart J. 2017 Aug 29. doi: 10.1093.
     PubMed     Abstract available
     
     
     
249. IBANEZ B, James S, Agewall S, Antunes MJ, et al
     2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European S
     Eur Heart J. 2017 Aug 26. doi: 10.1093.
     PubMed    
     
     
     
250. ESCANED J, Collet C, Ryan N, Luigi De Maria G, et al
     Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study.
     Eur Heart J. 2017 Aug 26. doi: 10.1093.
     PubMed     Abstract available
     
     
     
251. LASSALE C, Tzoulaki I, Moons KGM, Sweeting M, et al
     Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis.
     Eur Heart J. 2017 Aug 14. doi: 10.1093.
     PubMed     Abstract available
     
     
     
252. RIBEIRO HB, Rodes-Cabau J, Blanke P, Leipsic J, et al
     Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry.
     Eur Heart J. 2017 Aug 14. doi: 10.1093.
     PubMed     Abstract available
     
     
     
253. NEUMANN JT, Sorensen NA, Rubsamen N, Ojeda F, et al
     Discrimination of patients with type 2 myocardial infarction.
     Eur Heart J. 2017 Aug 13. doi: 10.1093.
     PubMed     Abstract available
     
     
     
254. D'ASCENZO F, Iannaccone M, Saint-Hilary G, Bertaina M, et al
     Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patients.
     Eur Heart J. 2017 Aug 11. doi: 10.1093.
     PubMed     Abstract available
     
     
     
255. KHAN AR, Golwala H, Tripathi A, Bin Abdulhak AA, et al
     Impact of total occlusion of culprit artery in acute non-ST elevation myocardial infarction: a systematic review and meta-analysis.
     Eur Heart J. 2017 Aug 7. doi: 10.1093.
     PubMed     Abstract available
     
     
     July 2017
256. DE WAHA S, Patel MR, Granger CB, Ohman EM, et al
     Relationship between microvascular obstruction and adverse events following primary primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials.
     Eur Heart J. 2017 Jul 28. doi: 10.1093.
     PubMed     Abstract available
     
     
     
257. VRANCKX P, Windecker S, Welsh RC, Valgimigli M, et al
     Thrombo-embolic prevention after transcatheter aortic valve implantation.
     Eur Heart J. 2017 Jul 25. doi: 10.1093.
     PubMed     Abstract available
     
     
     
258. HOPEWELL JC, Malik R, Valdes-Marquez E, Worrall BB, et al
     Differential effects of PCSK9 variants on risk of coronary disease and ischaemic stroke.
     Eur Heart J. 2017 Jul 17. doi: 10.1093.
     PubMed     Abstract available
     
     
     
259. POTHINENI NVK, Subramany S, Kuriakose K, Shirazi LF, et al
     Infections, atherosclerosis, and coronary heart disease.
     Eur Heart J. 2017 Jul 12. doi: 10.1093.
     PubMed     Abstract available
     
     
     May 2017
260. ZITTERMANN A, Ernst JB, Prokop S, Fuchs U, et al
     Effect of vitamin D on all-cause mortality in heart failure (EVITA): a 3-year randomized clinical trial with 4000 IU vitamin D daily.
     Eur Heart J. 2017 May 12. doi: 10.1093.
     PubMed     Abstract available
     
     
     April 2017
261. SINGH-MANOUX A, Fayosse A, Sabia S, Canonico M, et al
     Atrial fibrillation as a risk factor for cognitive decline and dementia.
     Eur Heart J. 2017 Apr 29. doi: 10.1093.
     PubMed     Abstract available
     
     
     
262. VRANCKX P, Frigoli E, Rothenbuhler M, Tomassini F, et al
     Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation.
     Eur Heart J. 2017;38:1069-1080.
     PubMed     Abstract available
     
     
     
263. GABET A, Danchin N, Juilliere Y, Olie V, et al
     Acute coronary syndrome in women: rising hospitalizations in middle-aged French women, 2004-14.
     Eur Heart J. 2017;38:1060-1065.
     PubMed     Abstract available
     
     
     
264. PALMERINI T, Della Riva D, Benedetto U, Bacchi Reggiani L, et al
     Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients.
     Eur Heart J. 2017;38:1034-1043.
     PubMed     Abstract available
     
     
     
265. GEBHARD C
     Women and acute coronary syndromes: still up to no good.
     Eur Heart J. 2017;38:1066-1068.
     PubMed    
     
     
     
266. ONUMA Y, Serruys PW
     Freedom from long DAPT signals the demise of the bare-metal stent.
     Eur Heart J. 2017;38:970-973.
     PubMed    
     
     
     
267. CARLSSON M
     The impacts on healthcare when coronary angiography as the reference method for diagnostic accuracy of coronary artery disease is replaced by fractional flow reserve!
     Eur Heart J. 2017;38:999-1001.
     PubMed    
     
     
     March 2017
268. LI XS, Obeid S, Klingenberg R, Gencer B, et al
     Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.
     Eur Heart J. 2017;38:814-824.
     PubMed     Abstract available
     
     
     
269. JIA H, Dai J, Hou J, Xing L, et al
     Effective anti-thrombotic therapy without stenting: intravascular optical coherence tomography-based management in plaque erosion (the EROSION study).
     Eur Heart J. 2017;38:792-800.
     PubMed     Abstract available
     
     
     February 2017
270. LYALL DM, Celis-Morales CA, Anderson J, Gill JM, et al
     Associations between single and multiple cardiometabolic diseases and cognitive abilities in 474 129 UK Biobank participants.
     Eur Heart J. 2017;38:577-583.
     PubMed     Abstract available
     
     
     
271. MORTENSEN MB, Nordestgaard BG, Afzal S, Falk E, et al
     ACC/AHA guidelines superior to ESC/EAS guidelines for primary prevention with statins in non-diabetic Europeans: the Copenhagen General Population Study.
     Eur Heart J. 2017;38:586-594.
     PubMed     Abstract available
     
     
     
272. DEFILIPPIS AP, Young R, McEvoy JW, Michos ED, et al
     Risk score overestimation: the impact of individual cardiovascular risk factors and preventive therapies on the performance of the American Heart Association-American College of Cardiology-Atherosclerotic Cardiovascular Disease risk score in a modern
     Eur Heart J. 2017;38:598-608.
     PubMed     Abstract available
     
     
     
273. SHUN-SHIN MJ, Zheng SL, Cole GD, Howard JP, et al
     Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials.
     Eur Heart J. 2017 Feb 21. doi: 10.1093.
     PubMed     Abstract available
     
     
     
274. MATHUR A, Fernandez-Aviles F, Dimmeler S, Hauskeller C, et al
     The consensus of the Task Force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for the treatment of acute myocardial infarction and heart failure: update 2016.
     Eur Heart J. 2017 Feb 15. doi: 10.1093.
     PubMed    
     
     
     
275. ODAKA Y, Takahashi J, Tsuburaya R, Nishimiya K, et al
     Plasma concentration of serotonin is a novel biomarker for coronary microvascular dysfunction in patients with suspected angina and unobstructive coronary arteries.
     Eur Heart J. 2017;38:489-496.
     PubMed     Abstract available
     
     
     
276. KARAKAS M, Schulte C, Appelbaum S, Ojeda F, et al
     Circulating microRNAs strongly predict cardiovascular death in patients with coronary artery disease-results from the large AtheroGene study.
     Eur Heart J. 2017;38:516-523.
     PubMed     Abstract available
     
     
     
277. MOTWANI M, Dey D, Berman DS, Germano G, et al
     Machine learning for prediction of all-cause mortality in patients with suspected coronary artery disease: a 5-year multicentre prospective registry analysis.
     Eur Heart J. 2017;38:500-507.
     PubMed     Abstract available
     
     
     
278. PRIES AR, Reglin B
     Coronary microcirculatory pathophysiology: can we afford it to remain a black box?
     Eur Heart J. 2017;38:478-488.
     PubMed     Abstract available
     
     
     
279. NIELSEN LH, Botker HE, Sorensen HT, Schmidt M, et al
     Prognostic assessment of stable coronary artery disease as determined by coronary computed tomography angiography: a Danish multicentre cohort study.
     Eur Heart J. 2017;38:413-421.
     PubMed     Abstract available
     
     
     
280. VAN DER VALK FM, Kuijk C, Verweij SL, Stiekema LCA, et al
     Increased haematopoietic activity in patients with atherosclerosis.
     Eur Heart J. 2017;38:425-432.
     PubMed     Abstract available
     
     
     
281. BOURANTAS CV, Jaffer FA, Gijsen FJ, van Soest G, et al
     Hybrid intravascular imaging: recent advances, technical considerations, and current applications in the study of plaque pathophysiology.
     Eur Heart J. 2017;38:400-412.
     PubMed     Abstract available
     
     
     
282. LEIPSIC J, Blanke P
     Prognostic value of coronary CT angiography: lessons from the West Denmark Cardiac Registry.
     Eur Heart J. 2017;38:422-424.
     PubMed    
     
     
     
283. CIMATO TR
     Persistent stem cell-driven inflammation in patients with prior MI and stroke.
     Eur Heart J. 2017;38:433-435.
     PubMed    
     
     
     December 2016
284. BARTUNEK J, Terzic A, Davison BA, Filippatos GS, et al
     Cardiopoietic cell therapy for advanced ischemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial.
     Eur Heart J. 2016 Dec 23. pii: ehw543. doi: 10.1093.
     PubMed     Abstract available
     
     
     
285. PELLICANO M, De Bruyne B, Toth GG, Casselman F, et al
     Fractional flow reserve to guide and to assess coronary artery bypass grafting.
     Eur Heart J. 2016 Dec 23. pii: ehw505. doi: 10.1093.
     PubMed     Abstract available
     
     
     November 2016
286. RYAN N, Escaned J
     Myocardial bridge as a cause of persistent post percutaneous coronary intervention angina identified with exercise intracoronary physiology.
     Eur Heart J. 2016.
     PubMed    
     
     
     October 2016
287. CREA F, Bairey Merz CN, Beltrame JF, Kaski JC, et al
     The parallel tales of microvascular angina and heart failure with preserved ejection fraction: a paradigm shift.
     Eur Heart J. 2016.
     PubMed    
     
     
     
288. ALFONSO F, Rivero F
     Coronary revascularization in diabetic patients with chronic kidney disease.
     Eur Heart J. 2016.
     PubMed    
     
     
     September 2016
289. JORGE C, Hiltrop N, Desmet W
     Heart failure with preserved ejection fraction: blame the veins....
     Eur Heart J. 2016.
     PubMed    
     
     
     
290. KOYAMA M, Yano T, Kikuchi K, Nagahara D, et al
     Lethal heart failure with anti-mitochondrial antibody: an arrhythmogenic right ventricular cardiomyopathy mimetic.
     Eur Heart J. 2016.
     PubMed    
     
     
     August 2016
291. YAMAJI K, Raber L, Zanchin T, Spitzer E, et al
     Ten-year clinical outcomes of first-generation drug-eluting stents: the Sirolimus-Eluting vs. Paclitaxel-Eluting Stents for Coronary Revascularization (SIRTAX) VERY LATE trial.
     Eur Heart J. 2016.
     PubMed     Abstract available
     
     
     
292. BABER U, Farkouh ME, Arbel Y, Muntner P, et al
     Comparative efficacy of coronary artery bypass surgery vs. percutaneous coronary intervention in patients with diabetes and multivessel coronary artery disease with or without chronic kidney disease.
     Eur Heart J. 2016.
     PubMed     Abstract available
     
     
     
293. EISEN A, Cannon CP, Blazing MA, Bohula EA, et al
     The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial.
     Eur Heart J. 2016.
     PubMed     Abstract available
     
     
     June 2016
294. HEIDBUCHEL H, Verhamme P, Alings M, Antz M, et al
     Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary.
     Eur Heart J. 2016.
     PubMed     Abstract available
     
     
     May 2016
295. PONIKOWSKI P, Voors AA, Anker SD, Bueno H, et al
     2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contributio
     Eur Heart J. 2016.
     PubMed    
     
     
     April 2016
296. MADONNA R, Van Laake LW, Davidson SM, Engel FB, et al
     Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure.
     Eur Heart J. 2016.
     PubMed     Abstract available
     
     
     February 2016
297. DIENER HC, Aisenberg J, Ansell J, Atar D, et al
     Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.
     Eur Heart J. 2016.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: